These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12522763)

  • 1. Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy.
    Butler JC; Lennox JL; McDougal LK; Sutcliffe JA; Tait-Kamradt A; Tenover FC
    Clin Infect Dis; 2003 Jan; 36(2):e19-25. PubMed ID: 12522763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
    Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
    Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
    Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M
    Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia.
    Cattoir V; Merabet L; Legrand P; Soussy CJ; Leclercq R
    J Antimicrob Chemother; 2007 May; 59(5):1010-2. PubMed ID: 17434877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
    Gulay Z; Ozbek OA; Bicmen M; Gur D
    Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ; Jenkins SG
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pneumococcal pneumonia.
    Pallares R
    Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA.
    Wu CM; Wu H; Ning Y; Wang J; Du X; Shen J
    FEMS Microbiol Lett; 2005 Jun; 247(2):199-205. PubMed ID: 15936901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
    Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK;
    J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae.
    Lonks JR; Garau J; Gomez L; Xercavins M; Ochoa de Echagüen A; Gareen IF; Reiss PT; Medeiros AA
    Clin Infect Dis; 2002 Sep; 35(5):556-64. PubMed ID: 12173129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
    Calatayud L; Ardanuy C; Cercenado E; Fenoll A; Bouza E; Pallares R; Martín R; Liñares J
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3240-6. PubMed ID: 17606677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.
    Reinert RR; Franken C; van der Linden M; Lütticken R; Cil M; Al-Lahham A
    Int J Antimicrob Agents; 2004 Jul; 24(1):43-7. PubMed ID: 15225860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.
    Jacobs MR
    Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130
    [No Abstract]   [Full Text] [Related]  

  • 18. Austrian syndrome caused by highly penicillin-resistant Streptococcus pneumoniae.
    Muñoz P; Sainz J; Rodríguez-Creixéms M; Santos J; Alcalá L; Bouza E
    Clin Infect Dis; 1999 Dec; 29(6):1591-2. PubMed ID: 10585831
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.